These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 31783698)
1. Palm Tocotrienol-Adjuvanted Dendritic Cells Decrease Expression of the Abdul Hafid SR; Radhakrishnan AK Vaccines (Basel); 2019 Nov; 7(4):. PubMed ID: 31783698 [No Abstract] [Full Text] [Related]
2. Tocotrienol-adjuvanted dendritic cells inhibit tumor growth and metastasis: a murine model of breast cancer. Abdul Hafid SR; Chakravarthi S; Nesaretnam K; Radhakrishnan AK PLoS One; 2013; 8(9):e74753. PubMed ID: 24069344 [TBL] [Abstract][Full Text] [Related]
3. Tocotrienols are good adjuvants for developing cancer vaccines. Hafid SR; Radhakrishnan AK; Nesaretnam K BMC Cancer; 2010 Jan; 10():5. PubMed ID: 20051142 [TBL] [Abstract][Full Text] [Related]
4. Tocotrienol-rich fraction from palm oil affects gene expression in tumors resulting from MCF-7 cell inoculation in athymic mice. Nesaretnam K; Ambra R; Selvaduray KR; Radhakrishnan A; Reimann K; Razak G; Virgili F Lipids; 2004 May; 39(5):459-67. PubMed ID: 15506241 [TBL] [Abstract][Full Text] [Related]
5. Palm tocotrienols inhibit proliferation of murine mammary cancer cells and induce expression of interleukin-24 mRNA. Selvaduray KR; Radhakrishnan AK; Kutty MK; Nesaretnam K J Interferon Cytokine Res; 2010 Dec; 30(12):909-16. PubMed ID: 21121862 [TBL] [Abstract][Full Text] [Related]
6. Combination therapy with tumor-lysate pulsed dendritic cells and antiangiogenic drug TNP-470 for mouse pancreatic cancer. Miyazaki J; Tsuzuki Y; Matsuzaki K; Hokari R; Okada Y; Kawaguchi A; Nagao S; Itoh K; Miura S Int J Cancer; 2005 Nov; 117(3):499-505. PubMed ID: 15906361 [TBL] [Abstract][Full Text] [Related]
7. In vitro induction of specific anti-tumoral immunity against laryngeal carcinoma by using human interleukin-12 gene-transfected dendritic cells. Liang W; Wang XF Chin Med J (Engl); 2011 May; 124(9):1357-61. PubMed ID: 21740748 [TBL] [Abstract][Full Text] [Related]
8. Phenotypic profile of dendritic and T cells in the lymph node of Balb/C mice with breast cancer submitted to dendritic cells immunotherapy. da Cunha A; Antoniazi Michelin M; Cândido Murta EF Immunol Lett; 2016 Sep; 177():25-37. PubMed ID: 27423825 [TBL] [Abstract][Full Text] [Related]
9. [Anti-leukemia activity of T cells impacted by dendritic cells added with sodium selenite]. Yang L; Liu FQ; Wang JW; Wu YP; Ding J Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Aug; 16(4):892-7. PubMed ID: 18718085 [TBL] [Abstract][Full Text] [Related]
10. Tocotrienol-rich fraction (TRF) suppresses the growth of human colon cancer xenografts in Balb/C nude mice by the Wnt pathway. Zhang JS; Zhang SJ; Li Q; Liu YH; He N; Zhang J; Zhou PH; Li M; Guan T; Liu JR PLoS One; 2015; 10(3):e0122175. PubMed ID: 25807493 [TBL] [Abstract][Full Text] [Related]
11. Palm tocotrienols decrease levels of pro-angiogenic markers in human umbilical vein endothelial cells (HUVEC) and murine mammary cancer cells. Selvaduray KR; Radhakrishnan AK; Kutty MK; Nesaretnam K Genes Nutr; 2012 Jan; 7(1):53-61. PubMed ID: 21526401 [TBL] [Abstract][Full Text] [Related]
12. [Allogeneic dendritic cell vaccine pulsed with heat shocked tumor cell lysate can enhance antitumor immunity]. You J; Wang CL; Hao XS Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(39):2785-90. PubMed ID: 18167273 [TBL] [Abstract][Full Text] [Related]
13. Enhanced protective immunity derived from dendritic cells with phagocytosis of CD40 ligand transgene-engineered apoptotic tumor cells via increased dendritic cell maturation. Parameswaran S; Khalil M; Ahmed KA; Sharma RK; Xiang J Tumori; 2015; 101(6):637-43. PubMed ID: 25983089 [TBL] [Abstract][Full Text] [Related]
14. Tocotrienol-rich fraction from palm oil and gene expression in human breast cancer cells. Nesaretnam K; Ambra R; Selvaduray KR; Radhakrishnan A; Canali R; Virgili F Ann N Y Acad Sci; 2004 Dec; 1031():143-57. PubMed ID: 15753141 [TBL] [Abstract][Full Text] [Related]
15. [Study on the specific immunity of dendritic cell vaccine loading human umbilical vein endothelial cell antigen against U14 cervical cancer]. Zhao J; Zhai JM; Lu J; Yang HY; Huang YT; Li S; Dong ZM; Zhang X Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 Mar; 25(3):196-200. PubMed ID: 19257979 [TBL] [Abstract][Full Text] [Related]
16. Enhanced HER-2/neu-specific antitumor immunity by cotransduction of mouse dendritic cells with two genes encoding HER-2/neu and alpha tumor necrosis factor. Chen Z; Huang H; Chang T; Carlsen S; Saxena A; Marr R; Xing Z; Xiang J Cancer Gene Ther; 2002 Sep; 9(9):778-86. PubMed ID: 12189528 [TBL] [Abstract][Full Text] [Related]
17. Systemic administration of interleukin 2 enhances the therapeutic efficacy of dendritic cell-based tumor vaccines. Shimizu K; Fields RC; Giedlin M; Mulé JJ Proc Natl Acad Sci U S A; 1999 Mar; 96(5):2268-73. PubMed ID: 10051630 [TBL] [Abstract][Full Text] [Related]
19. Effect of a cancer vaccine prepared by fusions of hepatocarcinoma cells with dendritic cells. Zhang J; Zhang JK; Zhuo SH; Chen HB World J Gastroenterol; 2001 Oct; 7(5):690-4. PubMed ID: 11819855 [TBL] [Abstract][Full Text] [Related]
20. Suppression of tumor growth by palm tocotrienols via the attenuation of angiogenesis. Weng-Yew W; Selvaduray KR; Ming CH; Nesaretnam K Nutr Cancer; 2009; 61(3):367-73. PubMed ID: 19373610 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]